Gary R. Manchee

520 total citations
16 papers, 372 citations indexed

About

Gary R. Manchee is a scholar working on Molecular Biology, Pharmacology and Animal Science and Zoology. According to data from OpenAlex, Gary R. Manchee has authored 16 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pharmacology and 4 papers in Animal Science and Zoology. Recurrent topics in Gary R. Manchee's work include Pharmacogenetics and Drug Metabolism (6 papers), Receptor Mechanisms and Signaling (4 papers) and Pharmacological Effects and Assays (4 papers). Gary R. Manchee is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Receptor Mechanisms and Signaling (4 papers) and Pharmacological Effects and Assays (4 papers). Gary R. Manchee collaborates with scholars based in United Kingdom, Finland and Italy. Gary R. Manchee's co-authors include Michael W.H. Coughtrie, Rana Dajani, Sandeep Modi, Alan M. Hood, Anne Cleasby, Harren Jhoti, Jyrki Taskinen, Alan J. Wonacott, Anne Hersey and Margarete Neu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Journal of Chromatography A.

In The Last Decade

Gary R. Manchee

16 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary R. Manchee United Kingdom 10 174 129 73 50 50 16 372
Stanley R. Howell United States 11 151 0.9× 118 0.9× 39 0.5× 61 1.2× 46 0.9× 20 452
Susanna Tse United States 14 146 0.8× 118 0.9× 40 0.5× 61 1.2× 88 1.8× 26 474
Stellan Swedmark Sweden 14 282 1.6× 219 1.7× 55 0.8× 15 0.3× 98 2.0× 26 576
James A. Oppermann United States 11 100 0.6× 49 0.4× 86 1.2× 36 0.7× 29 0.6× 17 495
G.T. Nagel Netherlands 15 180 1.0× 36 0.3× 32 0.4× 26 0.5× 78 1.6× 33 474
George Lukas Switzerland 7 97 0.6× 64 0.5× 41 0.6× 50 1.0× 48 1.0× 12 445
D. R. FELLER United States 13 242 1.4× 135 1.0× 76 1.0× 68 1.4× 47 0.9× 47 533
Minoru Tsuboi Japan 11 165 0.9× 51 0.4× 65 0.9× 27 0.5× 49 1.0× 36 414
Dwight D. Stiff United States 13 158 0.9× 121 0.9× 18 0.2× 21 0.4× 69 1.4× 18 444
M. Volz Germany 10 150 0.9× 49 0.4× 26 0.4× 36 0.7× 45 0.9× 24 422

Countries citing papers authored by Gary R. Manchee

Since Specialization
Citations

This map shows the geographic impact of Gary R. Manchee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary R. Manchee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary R. Manchee more than expected).

Fields of papers citing papers by Gary R. Manchee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary R. Manchee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary R. Manchee. The network helps show where Gary R. Manchee may publish in the future.

Co-authorship network of co-authors of Gary R. Manchee

This figure shows the co-authorship network connecting the top 25 collaborators of Gary R. Manchee. A scholar is included among the top collaborators of Gary R. Manchee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary R. Manchee. Gary R. Manchee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Leslie, Colin P., Matteo Biagetti, Steven M. Bromidge, et al.. (2010). Discovery of 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, Selective, and Orally Active 5-HT1A/B/D Receptor Antagonist. Journal of Medicinal Chemistry. 53(23). 8228–8240. 10 indexed citations
2.
3.
4.
Dajani, Rana, Anne Cleasby, Margarete Neu, et al.. (1999). X-ray Crystal Structure of Human Dopamine Sulfotransferase, SULT1A3. Journal of Biological Chemistry. 274(53). 37862–37868. 123 indexed citations
5.
6.
Manchee, Gary R., et al.. (1997). Purification and characterization of a canine liver phenol sulfotransferase.. PubMed. 25(10). 1205–10. 6 indexed citations
7.
Eddershaw, Peter, et al.. (1996). Absorption and disposition of ranitidine hydrochloride in rat and dog. Xenobiotica. 26(9). 947–956. 13 indexed citations
8.
Manchee, Gary R., et al.. (1996). The aliphatic oxidation of salmeterol to alpha-hydroxysalmeterol in human liver microsomes is catalyzed by CYP3A.. PubMed. 24(5). 555–9. 24 indexed citations
9.
Cannell, Richard J. P., Andrew R. Knaggs, Michael J. Dawson, et al.. (1995). Microbial biotransformation of the angiotensin II antagonist GR117289 by Streptomyces rimosus to identify a mammalian metabolite.. Drug Metabolism and Disposition. 23(7). 724–729. 21 indexed citations
10.
Murkitt, G.S., et al.. (1994). Fully automated assay for the determination of GR117289X in human plasma using mixed mode solid-phase extraction and high-performance liquid chromatography with ultraviolet detection. Journal of Pharmaceutical and Biomedical Analysis. 12(9). 1181–1187. 3 indexed citations
11.
Bowers, Gary D., et al.. (1994). Characterization of glucuronic acid conjugates of a novel angiotensin receptor antagonist. Rapid Communications in Mass Spectrometry. 8(2). 217–221. 5 indexed citations
12.
Middlemiss, David, Steve P. Watson, Barry C. Ross, et al.. (1993). Benzofuran based angiotensi II antagonists related to GR117289: Part II; amino acid amides. Bioorganic & Medicinal Chemistry Letters. 3(10). 2043–2046. 3 indexed citations
13.
Manchee, Gary R., et al.. (1993). Disposition of salmeterol xinafoate in laboratory animals and humans.. Drug Metabolism and Disposition. 21(6). 1022–1028. 35 indexed citations
14.
Rogers, H. L., P.J. Birch, Susan M. Harrison, et al.. (1992). GR94839, a κ‐opioid agonist with limited access to the central nervous system, has antinociceptive activity. British Journal of Pharmacology. 106(4). 783–789. 34 indexed citations
15.
Bowers, Gary D., et al.. (1991). Thermospray liquid chromatography-mass spectrometry for the characterization of sulphate ester conjugates. Journal of Chromatography A. 554(1-2). 175–180. 5 indexed citations
16.
Bradbury, A.F., et al.. (1983). The metabolism of loxtidine in rat and dog. Biochemical Society Transactions. 11(6). 715–716. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanley R. Howell Breakdown of academic impact, for papers by Susanna Tse Breakdown of academic impact, for papers by Stellan Swedmark Breakdown of academic impact, for papers by James A. Oppermann Breakdown of academic impact, for papers by G.T. Nagel Breakdown of academic impact, for papers by George Lukas Breakdown of academic impact, for papers by D. R. FELLER Breakdown of academic impact, for papers by Minoru Tsuboi Breakdown of academic impact, for papers by Dwight D. Stiff Breakdown of academic impact, for papers by M. Volz
Rankless by CCL
2026